HK135494A - Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient - Google Patents

Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient

Info

Publication number
HK135494A
HK135494A HK135494A HK135494A HK135494A HK 135494 A HK135494 A HK 135494A HK 135494 A HK135494 A HK 135494A HK 135494 A HK135494 A HK 135494A HK 135494 A HK135494 A HK 135494A
Authority
HK
Hong Kong
Prior art keywords
embonate
azelastin
active ingredient
pharmaceutical compositions
preparation
Prior art date
Application number
HK135494A
Other languages
English (en)
Inventor
Gerhard Dr Scheffler
Dieter Sauerbier
Juergen Dr Engel
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of HK135494A publication Critical patent/HK135494A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK135494A 1987-11-13 1994-12-01 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient HK135494A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3738641 1987-11-13
SG153894A SG153894G (en) 1987-11-13 1994-10-21 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient

Publications (1)

Publication Number Publication Date
HK135494A true HK135494A (en) 1994-12-09

Family

ID=25861795

Family Applications (1)

Application Number Title Priority Date Filing Date
HK135494A HK135494A (en) 1987-11-13 1994-12-01 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient

Country Status (9)

Country Link
EP (1) EP0316639B1 (ja)
JP (1) JP2730581B2 (ja)
AT (1) ATE106883T1 (ja)
CA (1) CA1317595C (ja)
DE (1) DE3850044D1 (ja)
DK (1) DK170339B1 (ja)
ES (1) ES2053679T3 (ja)
HK (1) HK135494A (ja)
SG (1) SG153894G (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0396069T3 (da) * 1989-05-05 1994-07-25 Asta Medica Ag Salte af azelastin med forbedret opløselighed
JPH04198180A (ja) * 1990-11-28 1992-07-17 Eezai Kagaku Kk ベンジルフタラゾン誘導体の製造方法
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
NZ555501A (en) 2004-11-24 2010-01-29 Medpointe Healthcare Inc Compositions comprising azelastine and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH572914A5 (ja) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab

Also Published As

Publication number Publication date
DK170339B1 (da) 1995-08-07
DK630088D0 (da) 1988-11-11
SG153894G (en) 1995-03-17
EP0316639B1 (de) 1994-06-08
JP2730581B2 (ja) 1998-03-25
DK630088A (da) 1989-05-14
DE3850044D1 (de) 1994-07-14
ES2053679T3 (es) 1994-08-01
ATE106883T1 (de) 1994-06-15
EP0316639A2 (de) 1989-05-24
CA1317595C (en) 1993-05-11
JPH01153686A (ja) 1989-06-15
EP0316639A3 (en) 1990-07-18

Similar Documents

Publication Publication Date Title
TW272195B (ja)
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
IL101358A0 (en) Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it
EP0293751A3 (en) Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
DE59001121D1 (en) Antacidatabletten.
HK135494A (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
IL61989A (en) 1-(1,3,4-oxadiazolyl-phenoxy)-3-(phenylpiperazino)propan-2-ols and their derivatives,their preparation and pharmaceutical compositions containing them
TW218011B (ja)
AU8452891A (en) Calcium uptake inhibitors
AU2506188A (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
UA32583C2 (uk) Похідні арилтіоалкілтіопіридину
AU1621888A (en) Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes
JO1531B1 (en) New near-compounds
JO1843B1 (en) Benzimercool vehicles carry alternatives and processes for their preparation and use in a pharmacy
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
IE873354L (en) New pyrrolobenzimidazoles, processes for the preparation¹thereof and pharmaceutical compositions containing them.

Legal Events

Date Code Title Description
PF Patent in force
CHPA Change of a particular in the register (except of change of ownership)
PE Patent expired

Effective date: 20081027